Checkpoint Therapeutics, Inc. (CKPT)
USD 3.57
(-3.9%)
USD 3.57
(-3.9%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 103 Thousand | 192 Thousand | 268 Thousand | 1.06 Million | 1.7 Million | 3.5 Million |
| Cost of Revenue | 43.56 Million | 49.82 Million | 48.45 Million | 16.35 Million | 19.32 Million | 33.65 Million |
| Gross Profit | -43.46 Million | -49.63 Million | -48.18 Million | -15.28 Million | -17.61 Million | -30.14 Million |
| Operating Expenses | 52.25 Million | 58.52 Million | 56.99 Million | 24.27 Million | 26.55 Million | 40.24 Million |
| Selling, General and Administrative Expenses | 8.68 Million | 8.7 Million | 8.53 Million | 7.91 Million | 7.23 Million | 6.59 Million |
| Research and Development Expenses | 43.56 Million | 49.82 Million | 48.45 Million | 16.35 Million | 19.32 Million | 33.65 Million |
| Other Expenses | - | - | - | - | - | 225 Thousand |
| Cost and Expenses | 52.25 Million | 58.52 Million | 56.99 Million | 24.27 Million | 26.55 Million | 40.24 Million |
| Operating Income | -52.14 Million | -58.33 Million | -56.72 Million | -23.2 Million | -24.85 Million | -36.74 Million |
| Interest Expense | - | 4.29 Million | - | - | - | - |
| Income Tax Expense | - | 4.29 Million | -53 Thousand | -120 Thousand | -136 Thousand | -521 Thousand |
| Earnings before Tax | -51.84 Million | -62.62 Million | -56.67 Million | -23.08 Million | -24.71 Million | -36.36 Million |
| Net Income | -51.84 Million | -66.91 Million | -56.61 Million | -22.96 Million | -24.57 Million | -36.36 Million |
| Earnings Per Share Basic | -2.77 | -7.57 | -7.45 | -4.11 | -6.96 | -12.74 |
| Earnings Per Share Diluted | -2.77 | -7.57 | -7.45 | -4.11 | -6.96 | -12.74 |
| Weighted Average Shares Outstanding | 18.74 Million | 8.83 Million | 7.6 Million | 5.58 Million | 3.53 Million | 2.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.74 Million | 8.83 Million | 7.6 Million | 5.58 Million | 3.53 Million | 2.85 Million |
| Gross Margin | -421.97 | -258.51 | -179.79 | -14.30 | -10.31 | -8.60 |
| EBIT Margin | -506.29 | -280.64 | -211.65 | -21.70 | -14.55 | -10.48 |
| Profit Margin | -503.37 | -348.52 | -211.26 | -21.48 | -14.39 | -10.37 |
| EBITDA | -52.14 Million | -58.33 Million | -56.72 Million | -23.2 Million | -24.85 Million | -36.74 Million |
| Earnings Before Tax Margin | -506.29 | -303.82 | -211.65 | -21.70 | -14.55 | -10.48 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 41 Thousand | - | 6000.00 | 103 Thousand | 31 Thousand | 31 Thousand |
| Cost of Revenue | 4.48 Million | 8.49 Million | 8.29 Million | 43.56 Million | 5.49 Million | 13.94 Million |
| Gross Profit | -4.43 Million | -8.49 Million | -8.29 Million | -43.46 Million | -5.46 Million | -13.91 Million |
| Operating Expenses | 6.71 Million | 10.94 Million | 10.17 Million | 52.25 Million | 7.73 Million | 16.22 Million |
| Selling, General and Administrative Expenses | 2.23 Million | 2.45 Million | 1.87 Million | - | 2.23 Million | 2.28 Million |
| Research and Development Expenses | 4.48 Million | 8.49 Million | 8.29 Million | - | 5.49 Million | 13.94 Million |
| Other Expenses | -4.48 Million | - | - | - | - | - |
| Cost and Expenses | 6.71 Million | 10.94 Million | 10.17 Million | 52.25 Million | 7.73 Million | 16.22 Million |
| Operating Income | -6.67 Million | -10.94 Million | -10.16 Million | -52.14 Million | -7.7 Million | -16.19 Million |
| Interest Expense | - | - | 7.6 Million | - | - | - |
| Income Tax Expense | - | -43.27 Thousand | 15.34 Million | -167.89 Thousand | -7.7 Million | -31 Thousand |
| Earnings before Tax | -6.67 Million | -10.94 Million | -19.12 Million | -51.84 Million | -5.72 Million | -16.52 Million |
| Net Income | -6.67 Million | -10.94 Million | -19.12 Million | -51.84 Million | -5.72 Million | -16.52 Million |
| Earnings Per Share Basic | -0.18 | -0.33 | -0.70 | - | -0.29 | -1.05 |
| Earnings Per Share Diluted | -0.18 | -0.33 | -0.70 | - | -0.29 | -1.05 |
| Weighted Average Shares Outstanding | 36.52 Million | 32.93 Million | 27.28 Million | 18.74 Million | 19.98 Million | 15.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.52 Million | 32.93 Million | 27.28 Million | 18.74 Million | 19.98 Million | 15.7 Million |
| Gross Margin | -108.27 | - | -1382.17 | -421.97 | -176.29 | -448.84 |
| EBIT Margin | -162.76 | - | -1694.83 | - | -248.42 | -510.90 |
| Profit Margin | -162.68 | - | -3188.00 | -503.37 | -184.65 | -532.94 |
| EBITDA | -6.67 Million | -10.94 Million | -10.16 Million | - | -7.7 Million | -15.83 Million |
| Earnings Before Tax Margin | -162.76 | - | -1694.83 | -506.29 | -248.42 | -522.42 |
CASY
0J9P
BXBLY
IAM
2616
4931